Solar lentigines (age spots): causes and treatment

Solar lentigines, commonly called age spots or sun spots, are flat, well-defined brown spots that develop in chronically sun-exposed areas such as the face, the backs of the hands, the shoulders, and the upper chest. They are an early visible sign of photoaging and result from cumulative ultraviolet exposure [1]. They are benign, but because a pigmented spot can occasionally mimic an early skin cancer, an accurate diagnosis comes before any cosmetic treatment.

This article explains what solar lentigines are, when a spot should be evaluated rather than treated cosmetically, and what the evidence supports for the main treatment options. It is not medical advice; diagnosis and treatment should be directed by a board-certified dermatologist.

What they are

Solar lentigines form where years of sun exposure increase local pigment production, leaving discrete tan to dark-brown macules with defined borders. They differ from melasma, which appears as larger symmetric patches influenced by hormones, and from freckles, which are smaller and fade in winter. Distinguishing solar lentigines from other pigmentation matters because the safe and effective treatment differs, as covered in our guide to telling facial pigmentation apart.

When to get a spot checked first

Most age spots are harmless, but a flat brown facial patch can occasionally be lentigo maligna, an early form of melanoma. A spot that is new in older age, enlarging, asymmetric, variably colored, or simply different from a person's other spots should be examined, and sometimes biopsied, before any laser or light treatment. Treating an undiagnosed atypical lesion cosmetically can delay a cancer diagnosis, so evaluation takes priority.

Treatment options

A systematic review of 41 clinical trials with more than 3,000 patients summarized the evidence for solar lentigines treatments [1]:

• Laser therapy and intense pulsed light were generally the most effective. Reported success ranged widely across device types, with picosecond and Q-switched lasers and intense pulsed light among the more effective, and pulsed dye and intense pulsed light associated with less post-inflammatory hyperpigmentation [1].
• Cryotherapy (freezing) was effective in a substantial proportion of cases but was linked to more side effects, including pigment change, than some light-based options [1].
• Chemical peels, such as trichloroacetic acid, were less effective on average than lasers [1].
• Topical agents, including a mequinol-tretinoin combination, were effective for facial lesions, and tyrosinase-inhibiting cosmeceuticals such as vitamin C and others are used as adjuncts that work gradually [1][2][3].

Combining a device with a topical agent may improve results and reduce post-inflammatory pigmentation, though larger trials are still needed to confirm the optimal approach [1].

Choosing by skin tone

The main safety consideration is post-inflammatory hyperpigmentation, which is more likely in Fitzpatrick III to VI skin. Device selection, conservative settings, and diligent sun protection lower that risk, and some light-based options are associated with less post-treatment pigmentation than others [1]. A dermatologist matches the method to the skin type to keep the risk low.

Prevention

Because solar lentigines reflect cumulative ultraviolet exposure, daily broad-spectrum sun protection both limits new spots and helps maintain treatment results [1]. Sun protection is the one measure that addresses the underlying cause; our photoprotection guide covers it in detail.

Adverse events, limitations, and realistic expectations

• Diagnosis first. An atypical or changing spot needs evaluation to exclude lentigo maligna before cosmetic treatment.
• Recurrence is common without ongoing sun protection, because the underlying photodamage continues [1].
• Post-inflammatory hyperpigmentation is the principal risk, especially in darker skin, and guides device choice and settings [1].
• Topicals are slower and generally less complete than light-based devices, and are often used in combination [1][3].
• Expected short-term effects of procedures include redness, crusting, temporary darkening, and pigment change, which vary by method [1].
• Evidence varies by device, and the systematic review calls for larger randomized trials to define the optimal approach [1].

Bottom line

Solar lentigines are benign markers of photoaging, but because they can mimic early skin cancer, diagnosis comes before cosmetic treatment [1]. Laser and intense pulsed light are generally the most effective options, topical agents help more gradually, and post-inflammatory hyperpigmentation is the key risk to manage, particularly in darker skin. Daily sun protection addresses the cause and helps results last.

This article is for informational purposes and does not constitute medical advice.